152 related articles for article (PubMed ID: 8560578)
1. The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease.
You-Ten KE; Lapp WS
Transplantation; 1996 Jan; 61(1):76-83. PubMed ID: 8560578
[TBL] [Abstract][Full Text] [Related]
2. Induction of a glucocorticoid-sensitive F1-anti-parental mechanism that affects engraftment during graft-versus-host disease.
You-Ten KE; Seemayer TA; Wisse B; Bertley FM; Lapp WS
J Immunol; 1995 Jul; 155(1):172-80. PubMed ID: 7602093
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
[TBL] [Abstract][Full Text] [Related]
4. The role of CD4+ and CD8+ cells in normal F1 hybrid host in the resistance to lethal graft-versus-host disease induction by transfer of parent spleen cells.
Kitajima T; Iwashiro M; Kuribayashi K; Imamura S
Immunol Lett; 1994 Jun; 40(3):207-10. PubMed ID: 7959888
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
Drobyski WR; Majewski D; Ozker K; Hanson G
J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
[TBL] [Abstract][Full Text] [Related]
6. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.
Palathumpat V; Dejbakhsh-Jones S; Strober S
Transplantation; 1995 Aug; 60(4):355-61. PubMed ID: 7652765
[TBL] [Abstract][Full Text] [Related]
7. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
8. T cell subsets in the thymus of graft-versus-host immunosuppressed mice. Sensitivity of the L3T4+Lyt-2- subset to cortisone.
Kornbluth M; You-Ten E; Desbarats J; Gamache S; Xenocostas A; Lapp WS
Transplantation; 1991 Jan; 51(1):262-7. PubMed ID: 1987697
[TBL] [Abstract][Full Text] [Related]
9. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
Johnson BD; Becker EE; Truitt RL
Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
[TBL] [Abstract][Full Text] [Related]
10. Biased liver T cell receptor V beta repertoire in a murine graft-versus-host disease model.
Howell CD; Li J; Roper E; Kotzin BL
J Immunol; 1995 Sep; 155(5):2350-8. PubMed ID: 7650370
[TBL] [Abstract][Full Text] [Related]
11. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
12. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
13. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
14. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity.
Sykes M; Abraham VS; Harty MW; Pearson DA
J Immunol; 1993 Jan; 150(1):197-205. PubMed ID: 8093257
[TBL] [Abstract][Full Text] [Related]
15. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
[TBL] [Abstract][Full Text] [Related]
16. Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis.
Zilberberg J; McElhaugh D; Gichuru LN; Korngold R; Friedman TM
J Immunol; 2008 Apr; 180(8):5352-9. PubMed ID: 18390717
[TBL] [Abstract][Full Text] [Related]
17. Roles of CD8+ and CD4+ cells on lethal graft-versus-host disease in nude mice.
Uenaka A; Kuribayashi K; Nakayama E
Transpl Immunol; 1993; 1(2):132-6. PubMed ID: 7915951
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of host CD8+ T lymphocytes in experimental graft-versus-host disease across a single major histocompatibility complex class II incompatibility.
de Lavareille A; Prigogine C; Paulart F; Nagy N; Habran C; Haddou NO; Le Moine A; Salmon I; Goldman M; Flamand V
Transplantation; 2005 Nov; 80(9):1293-9. PubMed ID: 16314798
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host disease.
Fast LD; Valeri CR; Crowley JP
Blood; 1995 Oct; 86(8):3090-6. PubMed ID: 7579403
[TBL] [Abstract][Full Text] [Related]
20. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
Friedman TM; Jones SC; Statton D; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Apr; 10(4):224-35. PubMed ID: 15077221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
